Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 14 (24), 8455-66

Synthesis and Activity of a New Class of Dual Acting Norepinephrine and Serotonin Reuptake Inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines

Affiliations

Synthesis and Activity of a New Class of Dual Acting Norepinephrine and Serotonin Reuptake Inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines

Paige E Mahaney et al. Bioorg Med Chem.

Abstract

Compounds with a combination of norepinephrine and serotonin reuptake inhibition have been approved in the US and Europe for a number of indications, including major depressive disorder and pain disorders such as diabetic neuropathy and fibromyalgia. Efforts to design selective norepinephrine reuptake inhibitors based on SAR from the aryloxypropanamine series of monoamine reuptake inhibitors have led to the identification of a potent new class of dual acting norepinephrine and serotonin reuptake inhibitors, namely the 3-(1H-indol-1-yl)-3-arylpropan-1-amines.

Similar articles

See all similar articles

Cited by 5 articles

MeSH terms

LinkOut - more resources

Feedback